期刊文献+

多替泊芬-光动力疗法肿瘤抑制效应的实验研究 被引量:1

Inhibition Effects of Photodynamic Therapy with Deuteporfin on Tumor Proliferation both in Vitro and in Vivo
原文传递
导出
摘要 目的观察多替泊芬-光动力疗法(photodynamic therapy,PDT)对肿瘤生长的抑制作用。方法 (1)体外杀伤效应实验,肿瘤细胞加药后孵育3h,采用波长627.8nm、功率密度20mW/cm2的激光照射300s,应用磺酰罗丹明B蛋白染色法(sulforhodamine B,SRB)检测多替泊芬对人口腔鳞癌细胞KB、人结肠腺癌细胞HCT-116、人胃腺癌细胞MKN-45、人宫颈上皮鳞癌细胞HELA、人食管癌细胞Eca-109、人膀胱癌细胞T-24等6株人实体瘤细胞增殖生长的抑制作用。(2)在体抗肿瘤效应实验,荷瘤裸小鼠单次静脉注射多替泊芬后1h,采用波长627.8nm、功率密度120mW/cm2的激光照射肿瘤30min,检测多替泊芬-PDT对裸小鼠人鳞癌KB、人胃腺癌MKN-28、人结肠腺癌HCT-116三种移植肿瘤的生长抑制作用。结果多替泊芬光动力治疗对6株人实体瘤细胞生长抑制的IC50为0.14~0.20μM;加药无激光照射时,对人实体瘤细胞无生长抑制作用。多替泊芬光动力疗法对人鳞癌KB、人胃腺癌MKN-28和人结肠腺癌HCT-116三种裸小鼠移植瘤有明显的生长抑制作用,该作用与药物剂量相关,10mg/kg多替泊芬光动力治疗后第24天上述三种移植瘤的相对肿瘤增值率分别为13.8%、11.7%、14.2%。结论多替泊芬-光动力疗法对本实验的6株人实体瘤细胞、三种实体瘤均有显著生长抑制作用,有较好的临床应用前景。 Objective To investigate the inhibition effects of photodynamic therapy (PDT) with deuteporfin on tumor proliferation. Methods Three hours after incubation with deuteporfin, tumor cells were irradiated with 627.8 nm laser (power density: 20 mW/ cm2) for 300 s. The inhibitory effect of deuteporfin-PDT on the proliferation of KB, HCT-116, MKN45, HELA, Eca-109, and T-24 were measured respectively with Sulforhodamine B (SRB) method. Nude mice with human tumor were given laser irradiation (power density :120 mW/cm2 , duration:30 minutes) 1 hour after intravenous injection of deuteporfin, and the inhibitory effect of deuteporfin- PDT on tumor proliferation was detected with human tumor nude mice xenografts as models in vivo study. Results The Cytotoxicity ICs0 values of deutepoffin-PDT were between 0. 14 p,M and 0.20 p.M on six human solid tumor cell lines. Without laser irradiation, deuteportin had no inhibitory effect on the proliferation of human solid tumor cell lines. Deuteporfin-PDT had significant inhibitory effect on tumor proliferation of human squamous (KB), gastroadenocarcinoma (MKN-28), and colon adenocarci- noma(HCT-116) xenograft models. The inhibitory effect was dosage dependent. The relative tumor proliferation rates of 10 mg/kg deu- teporfin-PDT group were 13.8% , 11.7% and 14. 2% respectively 24 days after the treatment. Conclusions Deuteporfin-PDT has significant proliferation inhibitory effect on solid tumors of different tissue sources.
出处 《中国激光医学杂志》 CAS CSCD 2013年第3期127-132,181,182,共8页 Chinese Journal of Laser Medicine & Surgery
基金 上海市科委生物医药重点科技攻关项目(05DZ19338)
关键词 光动力疗法 多替泊芬 抗肿瘤 裸小鼠移植瘤 Photodynamic therapy Deuteporfin Antitumor Nude mice xenograft
  • 相关文献

参考文献10

  • 1Skehan P, Storeng R, Scudiero D,et al. New colorimetric cytotoxicity assay for anticancer drug screening [ J ]. Jour- nal of the National Cancer Institute, 1990, 82 : 1107-1112.
  • 2Teicher BA, Andrews PA. Anticancer drug development guide: preclinical screening, clinical trials, and approval [M]. Totowa, NJ: Humana Press,2004. 125-152.
  • 3Dougherty TJ, Gomer C J, Henderson BW, et al. Photody- namic therapy[ J]. Journal of the National Cancer Institute, 1998, 90: 889-905.
  • 4McBride G. Studies expand potential uses of photodynamie therapy[ J]. Journal of the National Cancer Institute,2002, 94 : 1740-1742.
  • 5Sharman WM, Alien CM, van Lier JE. Photodynamic therapeutics: basic principles and clinical applications [J]. Drug Discovery Today, 1999, 4: 507-517.
  • 6Chatterjee DK, Fang LS, Zhang Y, et al. Nanoparticles in photodyuamic therapy: an emerging paradigm [ J ]. Ad- vanced Drug Delivery Reviews, 2008, 60: 1627-1637.
  • 7Wang R, Hao H, Wang G, et al. Pharmacokinetics, tis- sue distribution and excretion of a new photodynamic drug deuxemether[ J]. ournal of Photochemistry and Photobiol- ogy B: Biology, 2008, 90: 179-186.
  • 8宋坤,孔北华,曲讯,李莉,王文霞,杨兴升,张友忠,王波,姜洁,崔保霞,王立杰.血卟啉单甲醚用于卵巢上皮性癌光动力学治疗的实验研究[J].中华妇产科杂志,2006,41(5):348-350. 被引量:2
  • 9黄维甄,谢剑明,陈锦章,李荣,张兰英,李黎波,罗荣城.喜泊芬对人食管癌Eca-109细胞的光动力效应[J].中国临床医学,2010,17(6):880-882. 被引量:1
  • 10殷荣,赵井泉,黄乃艳,王颖,曾晶,朱建国,邓虹,顾瑛.竹红菌乙素及其衍生物对人胃腺癌细胞光动力杀伤效应的比较[J].中国激光医学杂志,2012,21(1):1-5. 被引量:3

二级参考文献23

  • 1许德余,陈文晖,张浩,沈念慈.光动力治癌新药血卟啉单甲醚(HMME)的研究[J].中国激光医学杂志,1993,2(1):3-7. 被引量:60
  • 2尚立群,周乃康,顾瑛,刘凡光,曾晶.竹红菌乙素-PDT与血卟啉衍生物-PDT对食管癌细胞杀伤效应的比较研究[J].肿瘤防治杂志,2005,12(15):1139-1142. 被引量:14
  • 3孙燕,石远凯.临床肿瘤内科手册[M].第5版,北京:人民卫生出版社,2008:711-717.
  • 4Rosenthal DI.Gatstein Clinical applications of photodynamic therapy[J].Ann Med,1994,26:405-409.
  • 5Epstein JH.Phototoxieity and photoallergy[J].Semin Cutan Med Surg,1999,18(4):74-84.
  • 6Price M,Reiners JJ,Santlago AM,et al.Monitoring singht oxygen and hydroxyl radical formation with fluorescent probes during photodynamie therapy[J].Photoehem Photobiol,2009,10(3):3-5.
  • 7Radua,Wagineres G,Vanden BH,et al.Photodynamic therapy of early squamous cell cancers of the esophagus[J].Gastrointest Chin N Am,2000,10(3):430-460.
  • 8Hilf R,Murant R S,Narayanan U,et al.Relationship of mitoehondria function and cellular adenosine triphosphate levels to hematoporphyrin defivatine-induced photosensitization in R3230 AC mammary tumorg[J].Cancer Res,1986,46(1):211-217.
  • 9Gibson SL,Vander Meid KR,Mutant RS,et al.Increased eficacy of photod ynamie therapy of R3230 AC mamlnary adenecarcinoma by intratumoral injection of photofrin I[J].Br J Cancer,1990,61(4):553-557.
  • 10Xin Liu,Jie Xie,Luyong Zhang,et al.A novel hypocrellin B derivative designed and synthesized by taking consideration to both drug delivery and biological photodynamic activity[J].Journal of Photochemistry and Photobiology B:Biology,2009,94:171-178.

共引文献3

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部